This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
$69.80
Share price
0.00%
Change (1 day)
127.12%
Change (1 year)
Categories
Albireo Pharma (ALBO) - Total assets
Total assets on the balance sheet as of September 2022 : A$0.50 Billion
According to Albireo Pharma's latest financial reports the company's total assets are A$0.50 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Albireo Pharma - Total assets on balance sheet (from 2005 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2021-12-31 | A$0.41 B | 12.17% |
| 2020-12-31 | A$0.37 B | 57.54% |
| 2019-12-31 | A$0.23 B | -10.45% |
| 2018-12-31 | A$0.26 B | 180.69% |
| 2017-12-31 | A$93.79 M | 36.14% |
| 2016-12-31 | A$68.89 M | |
| 2016-09-30 | A$37.84 M | -36.01% |
| 2015-09-30 | A$59.14 M | 102.78% |
| 2014-09-30 | A$29.16 M | -34.07% |
| 2013-09-30 | A$44.24 M | 11.62% |
| 2012-09-30 | A$39.63 M | -6.75% |
| 2011-09-30 | A$42.5 M | 26.33% |
| 2010-09-30 | A$33.64 M | -50.13% |
| 2009-09-30 | A$67.46 M | -45.16% |
| 2008-09-30 | A$0.12 B | 30.99% |
| 2007-09-30 | A$93.92 M | 275.51% |
| 2006-09-30 | A$25.01 M | 1489.58% |
| 2005-09-30 | A$1.57 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | A$0.43 B | -14.66% | 🇺🇸 USA |